EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease-Reference-Cited by-同舟云学术

EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease

Published:2019-02-04 Issue:3 Volume:34 Page:353-365
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Dafsari Haidar S.¹²^ORCID,Martinez‐Martin Pablo³,Rizos Alexandra²,Trost Maja⁴,Santos Ghilardi Maria Gabriela⁵,Reddy Prashanth²,Sauerbier Anna²⁶,Petry‐Schmelzer Jan Niklas¹,Kramberger Milica⁴,Borgemeester Robbert W. K.⁷,Barbe Michael T.¹,Ashkan Keyoumars²,Silverdale Monty⁸,Evans Julian⁸,Odin Per⁹¹⁰,Fonoff Erich Talamoni⁵¹¹,Fink Gereon R.¹¹²,Henriksen Tove¹³,Ebersbach Georg¹⁴,Pirtošek Zvezdan⁴,Visser‐Vandewalle Veerle¹⁵,Antonini Angelo¹⁶¹⁷^ORCID,Timmermann Lars¹¹⁸,Ray Chaudhuri K.²⁶^ORCID,

Affiliation:

1. Department of NeurologyUniversity Hospital Cologne Cologne Germany

2. National Parkinson Foundation International Centre of ExcellenceKing's College Hospital London United Kingdom

3. National Center of Epidemiology and CIBERNEDCarlos III Institute of Health Madrid Spain

4. Department of NeurologyUniversity Medical Center Ljubljana Ljubljana Slovenia

5. Department of Neurology, Institute of PsychiatryUniversity of São Paulo Medical School São Paulo Brazil

6. Institute of Psychiatry, Psychology and NeuroscienceKing's College London London United Kingdom

7. Department of NeurologyUniversity Medical Center Groningen, University of Groningen Groningen The Netherlands

8. Department of Neurology and Neurosurgery, Salford Royal Foundation TrustManchester Academic Health Science Centre, University of Manchester Greater Manchester United Kingdom

9. Department of NeurologyKlinikum‐Bremerhaven Bremerhaven Germany

10. Department of NeurologySkane University Hospital Lund Sweden

11. Laboratory of NeuromodulationInstitute of Teaching and Research, Hospital Sirio‐Libanês São Paulo Brazil

12. Cognitive NeuroscienceInstitute of Neuroscience and Medicine (INM‐3), Research Centre Jülich Jülich Germany

13. Movement Disorder ClinicUniversity Hospital of Bispebjerg Copenhagen Denmark

14. Movement Disorder ClinicKliniken Beelitz Beelitz‐Heilstätten Germany

15. Department of Stereotaxy and Functional NeurosurgeryUniversity Hospital Cologne Cologne Germany

16. Department for Parkinson's diseaseIRCCS Hospital San Camillo Venice Italy

17. Department of NeuroscienceUniversity of Padua Padua Italy

18. Department of NeurologyUniversity Hospital Giessen and Marburg Marburg Germany

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.27626

Reference49 articles.

1. A Randomized Trial of Deep-Brain Stimulation for Parkinson's Disease

2. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

3. Quality of life in Parkinson’s disease improved by apomorphine pump: the OPTIPUMP cohort study

4. Beneficial Effects of Bilateral Subthalamic Stimulation on Non-Motor Symptoms in Parkinson's Disease

5. EuroInf: AMulticenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ON/OFF non-motor evaluation: a new way to evaluate non-motor fluctuations in Parkinson’s disease;Journal of Neurology, Neurosurgery & Psychiatry;2024-01-25

2. Population pharmacokinetics of rotigotine extended‐release microspheres for intramuscular injection in patients with early‐stage Parkinson's disease;British Journal of Clinical Pharmacology;2024-01-17

3. How to Use the New European Academy of Neurology/Movement Disorder Society European Section Guideline for Invasive Therapies in Parkinson's Disease;Movement Disorders Clinical Practice;2024-01-12

4. Architecture of the subthalamic nucleus;Communications Biology;2024-01-10

5. Attitudes Toward the Adoption of Remote Patient Monitoring and Artificial Intelligence in Parkinson’s Disease Management: Perspectives of Patients and Neurologists;The Patient - Patient-Centered Outcomes Research;2024-01-05